purvalanol A
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Purvalanol A is a highly selective inhibitor of Cdc2 [also known as cyclin-dependent kinase 1 (CDK1)]. Taxol is an anti-tumor…
Abstract 1. Purine cyclin-dependent kinase inhibitors have recently been recognised as promising candidates for the treatment of…
Objectives: This project aimed to investigate effects of purvalanol A on imatinib-sensitive and -insensitive chronic myeloid…
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA
Akt is a serine/threonine kinase and an essential…
Cyclin-dependent kinase inhibitors (CDKi) have high potential applicability in anticancer therapy, but various aspects of their…
Several recent findings indicate that intensity of neurogenesis in adult brain might be regulated by enzymes involved in the cell…
Survivin is expressed in most tumor cells and has been associated with both anti-apoptosis and mitotic progression. However, the…